Related Experiment Videos
[Analysis of airway hyperresponsiveness using in vitro contraction model]
1Department of Pharmacology, Graduate School of Medical Sciences, Kyushu University, 812-8582, Japan.
Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica
|January 20, 2004
Summary
Theophylline inhibits airway hyperresponsiveness by blocking the RhoA/Rho-kinase pathway. This study demonstrates theophylline
Area of Science:
- Cell Biology
- Pharmacology
- Respiratory Medicine
Context:
- Airway hyperresponsiveness is a key feature of asthma.
- Lysophosphatidic acid (LPA) activates RhoA, a small G-protein implicated in smooth muscle contraction.
- An in vitro model using bovine tracheal smooth muscle cells (BTSMC) was developed to study airway hyperresponsiveness.
Purpose:
- To investigate the mechanism of LPA-induced airway smooth muscle hyperresponsiveness.
- To determine the effect of the Rho-kinase inhibitor Y-27632 and theophylline on this model.
- To elucidate the role of RhoA in mediating airway hyperresponsiveness.
Summary:
- Lysophosphatidic acid (LPA) significantly augmented ATP- and high K+-induced contraction in BTSMC-embedded collagen gels, an effect mediated by RhoA activation.
- The Rho-kinase inhibitor Y-27632 suppressed LPA-induced augmentation, while theophylline reversed it by inhibiting RhoA membrane translocation.
- These findings indicate that theophylline prevents airway hyperresponsiveness by inhibiting the RhoA/Rho-kinase pathway.
Impact:
- Provides a novel in vitro model for studying airway hyperresponsiveness.
- Identifies theophylline as a potential therapeutic agent for airway hyperresponsiveness.
- Elucidates the molecular mechanism underlying LPA-induced smooth muscle hyperresponsiveness, involving RhoA and Rho-kinase.